Functional Brands Faces Nasdaq Delisting After Prolonged Bid Deficiency
I'm LongbridgeAI, I can summarize articles.Functional Brands Inc. (MEHA) faces Nasdaq delisting after its stock traded at or below $0.10 for ten consecutive days, failing to meet the $1 minimum bid requirement. Trading is suspended starting June 16, 2026. Although the company may appeal, there is no guarantee of regaining compliance, creating uncertainty for shareholders and limiting access to public equity markets.
Functional Brands Inc ( (MEHA) ) just unveiled an update.
Functional Brands Inc., which develops and manufactures wellness and performance products including Kirkman nutritional supplements, P2i prenatal vitamins, and the Tru2u.health telehealth platform, operates an FDA-registered, cGMP-compliant facility in Oregon and distributes its brands in more than 35 countries. The company focuses on regulated, science-oriented health offerings aimed at consumers seeking targeted nutritional and wellness support.
On June 9, 2026, Functional Brands received a Nasdaq staff determination to delist its common stock from the Nasdaq Capital Market after the shares traded at or below $0.10 for ten consecutive days, following an earlier December 30, 2025 notice that the stock had failed to meet the $1.00 minimum bid requirement. Trading in the stock is scheduled to be suspended at the market open on June 16, 2026, and while the company may appeal to a Nasdaq hearings panel, the suspension will remain in place and there is no assurance it can regain compliance, raising uncertainty for shareholders and potentially constraining the company’s access to public equity markets.
More about Functional Brands Inc
Functional Brands Inc., traded on Nasdaq under the ticker MEHA, is a wellness and performance products company whose portfolio includes Kirkman, a long-established nutritional supplements brand sold in more than 35 countries. The company also offers the P2i by Kirkman prenatal multivitamin and multimineral line and operates Tru2u.health, a consumer-facing telehealth and wellness platform, supported by an FDA-registered, cGMP-compliant manufacturing facility in Oregon.
The firm positions itself as a leading innovator in the wellness space, emphasizing regulatory compliance and global distribution as key elements of its business model and growth strategy. Its mix of supplements, prenatal products, and digital health services targets consumers seeking science-based, health-focused solutions across multiple channels and geographies.
Average Trading Volume: 41,800,412
Technical Sentiment Signal: Strong Sell
Current Market Cap: $1.77M
Learn more about MEHA stock on TipRanks’ Stock Analysis page.